Arkema S.A.
Arkema S.A. (ARKAY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Arkema S.A. (ARKAY), covering cash flow, earnings, and balance sheets.
Arkema S.A. (ARKAY) Income Statement & Financial Overview
Explore comprehensive income reports for Arkema S.A. ARKAY, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.38B | $2.27B | $2.39B | $2.54B |
| Cost of Revenue | $1.94B | $1.85B | $1.92B | $1.97B |
| Gross Profit | $441.00M | $423.00M | $477.00M | $571.00M |
| Gross Profit Ratio | $0.19 | $0.19 | $0.20 | $0.23 |
| R&D Expenses | $71.00M | $94.00M | $47.00M | $68.00M |
| SG&A Expenses | $246.00M | $225.00M | $222.00M | $238.00M |
| Operating Expenses | $339.00M | $373.00M | $269.00M | $306.00M |
| Total Costs & Expenses | $2.28B | $2.22B | $2.21B | $2.27B |
| Interest Income | $0.00 | $0.00 | $0.00 | $3.00M |
| Interest Expense | $24.00M | $20.00M | $20.00M | $15.00M |
| Depreciation & Amortization | $205.00M | $187.00M | $200.00M | $186.00M |
| EBITDA | $329.00M | $87.00M | $408.00M | $451.00M |
| EBITDA Ratio | $0.14 | $0.04 | $0.17 | $0.18 |
| Operating Income | $102.00M | $50.00M | $208.00M | $265.00M |
| Operating Income Ratio | $0.04 | $0.02 | $0.09 | $0.10 |
| Other Income/Expenses (Net) | -$24.00M | -$22.00M | -$44.00M | -$64.00M |
| Income Before Tax | $78.00M | $28.00M | $164.00M | $202.00M |
| Income Before Tax Ratio | $0.03 | $0.01 | $0.07 | $0.08 |
| Income Tax Expense | $28.00M | $20.00M | $42.00M | $52.00M |
| Net Income | $49.00M | $12.00M | $118.00M | $145.00M |
| Net Income Ratio | $0.02 | $0.005 | $0.05 | $0.06 |
| EPS | $0.65 | $0.16 | $1.43 | $1.94 |
| Diluted EPS | $0.64 | $0.16 | $1.42 | $1.93 |
| Weighted Avg Shares Outstanding | $75.70M | $75.80M | $82.52M | $74.68M |
| Weighted Avg Shares Outstanding (Diluted) | $76.001M | $75.80M | $82.52M | $75.04M |
The company's financials show resilient growth, with revenue advancing from $2.54B in Q2 2024 to $2.38B in Q1 2025. Gross profit remained healthy with margins at 19% in Q1 2025 compared to 23% in Q2 2024. Operating income hit $102.00M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $329.00M. Net income rose to $49.00M, while earnings per share reached $0.65. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan